Palisade Bio Inc
Veridion Score
BETALOW CONF · 4/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PALI moving today?
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PALI overview
Related filings and maps
Congress activity in PALI
No receipt-qualified Congressional disclosure is present for PALI in the cached public ledger.
PALI contract awards, year to date.
Public federal awards linked to this ticker.
PALI lobbying filings, year to date.
Registered lobbying filings matched to Palisade Bio Inc.